Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates

J Antibiot (Tokyo). 2016 Mar;69(3):173-5. doi: 10.1038/ja.2015.101. Epub 2015 Oct 14.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / pharmacology*
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
  • China
  • Chlorpromazine / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / isolation & purification
  • Reserpine / pharmacology
  • Thioridazine / pharmacology
  • Tuberculosis, Pulmonary / blood
  • Tuberculosis, Pulmonary / drug therapy*
  • Verapamil / pharmacology

Substances

  • Antitubercular Agents
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • Reserpine
  • Verapamil
  • Thioridazine
  • Chlorpromazine